Purchase Order 75N92020K20029
- Not listed
- This is a $19,956.48 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) through a total small business set-aside. The contract is for the provision of medical supplies, devices, laboratory equipment, and diagnostic products by BD's IDS division, operating as BD Diagnostic Systems, to support government healthcare and biomedical...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The $15,997.60 Firm Fixed Price contract is a BPA Call, with an ultimate completion date of August 2, 2017. The contract does not have a set-aside designation, indicating BD competed effectively as a large medical technology manufacturer. The contract appears to be part of BD's broader portfolio of federal awards,...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Becton, Dickinson and Company (BD), a manufacturer of medical devices and supplies. The contract is for the provision of laboratory supplies with a potential value of $13,000.00 and a completion date of September 30, 2024. The contract does not have a set-aside designation. BD is a for-profit...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract has a potential value of $150,000.00 and a completion date of December 31, 2019. The contract does not have a set-aside designation. BD has received numerous federal contract awards, including with the Department...
- This federal contract was awarded by the National Institutes of Health (NIH) Clinical Center to Becton, Dickinson and Company (BD) to provide service agreement support services. The contract is a firm fixed-price Purchase Order with a ceiling value of $17,390.95 and an ultimate completion date of September 7, 2024. The contract is not set aside for any specific business type. BD, through its IDS division operating as BD Diagnostic Systems, is a prime contractor that has received over $500...
- This is a $21,708.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD), a leading global medical technology manufacturer, for other functions related to BD Diagnostic System products. The award has no set-aside designation. As a prime contractor, BD provides critical medical equipment, supplies, and testing services to federal agencies,...
- This federal contract award, with ID HHSN268201500187A, was made by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the procurement of in vitro diagnostic substances, reagents, test kits, and sets. The $388,820.00 firm fixed-price purchase order was issued to support the NHLBI Division of Intramural Research. The contract does not have a set-aside designation and was awarded on September 8,...
- This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
- This is a $6,532 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract is not set aside for any particular business category. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications, including through flow cytometry, cell imaging, and genomics...
This is a $2,734.08 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the provision of medical supplies and services. The contract has an ultimate completion date of September 29, 2025 and was awarded on September 28, 2020 without any set-aside designation. BD, a global medical technology company, will be delivering a range of critical medical equipment, reagents, and testing services through its IDS division to support NHLBI's healthcare and biomedical research programs. This includes the supply of specialized medical diagnostic equipment such as blood culture systems, microbiology analyzers, molecular and COVID-19 testing kits, and flow cytometry instruments. The contract award is associated with multiple indefinite delivery/indefinite quantity (IDIQ) contracts and Blanket Purchase Agreements (BPAs) held by BD with various federal agencies, including a $30 million multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs and a $2 million BPA for molecular and COVID-19 testing services with the VA's Veterans Integrated Service Network 19. These established contract vehicles enable streamlined procurement of BD's specialized medical technologies across government healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($8k) | 9/29/25 | |
| Not listed | Not listed | $10.9k | 9/8/20 |